"Liver-gut" axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease

被引：8
作者：
Guo, Kangxiao [1 ]
Xu, Sisheng [1 ]
Zeng, Zhaofeng [1 ]
机构：
[1] Changsha Hlth Vocat Coll, Changsha, Hunan, Peoples R China
来源：
FRONTIERS IN ENDOCRINOLOGY | 2022年 / 13卷
关键词：
liver-gut" axis; intestinal microorganisms; traditional Chinese medicine; NAFLD; target; MICROBIOTA; ANTIBIOTICS; FIBROSIS; GENES; ACIDS; MICE;
D O I：
10.3389/fendo.2022.1050709
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Non-alcoholic fatty liver disease (NAFLD) occurs when fat accumulates in the liver even without excessive alcohol intake. Among the current therapeutic approaches for NAFLD, lifestyle modification with dietary changes and regular exercise is the mainstay treatment. With the rise of intestinal microecology, regulation of the "liver-gut" axis can be an effective treatment for NAFLD. This review aimed to assess the modulation of the liver-gut microbiota axis with traditional Chinese medicine (TCM) as a therapeutic approach to NAFLD and further explored its application in the newly discovered therapeutic avenues beyond NAFLD treatment.
引用
收藏
页数：9
相关论文
共 63 条
  • [1] The gut-liver axis in liver disease: Pathophysiological basis for therapy
    Albillos, Agustin
    de Gottardi, Andrea
    Rescigno, Maria
    [J]. JOURNAL OF HEPATOLOGY, 2020, 72 (03) : 558 - 577
  • [2] Clinical heterogeneity in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma
    Anastasopoulos, Nikolaos-Andreas T.
    Lianos, Georgios D.
    Tatsi, Vera
    Karampa, Anastasia
    Goussia, Anna
    Glantzounis, Georgios K.
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (11) : 1025 - 1033
  • [3] The Natural Course of Non-Alcoholic Fatty Liver Disease
    Bertot, Luis Calzadilla
    Adams, Leon Anton
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (05)
  • [4] Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease
    Boursier, Jerome
    Diehl, Anna Mae
    [J]. PLOS PATHOGENS, 2015, 11 (01) : 1 - 6
  • [5] Gut- liver axis at the frontier of host-microbial interactions
    Brandl, Katharina
    Kumar, Vipin
    Eckmann, Lars
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2017, 312 (05): : G413 - G419
  • [6] Gut microbial metabolites in obesity, NAFLD and T2DM
    Canfora, Emanuel E.
    Meex, Ruth C. R.
    Venema, Koen
    Blaak, Ellen E.
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (05) : 261 - 273
  • [7] Microbiota-Liver Axis in Hepatic Disease
    Chassaing, Benoit
    Etienne-Mesmin, Lucie
    Gewirtz, Andrew T.
    [J]. HEPATOLOGY, 2014, 59 (01) : 328 - 339
  • [8] Antibiotics in early life alter the murine colonic microbiome and adiposity
    Cho, Ilseung
    Yamanishi, Shingo
    Cox, Laura
    Methe, Barbara A.
    Zavadil, Jiri
    Li, Kelvin
    Gao, Zhan
    Mahana, Douglas
    Raju, Kartik
    Teitler, Isabel
    Li, Huilin
    Alekseyenko, Alexander V.
    Blaser, Martin J.
    [J]. NATURE, 2012, 488 (7413) : 621 - +
  • [9] Cui X, 2017, MECH LIPID BENEFICIA
  • [10] The role of short-chain fatty acids in microbiota-gut-brain communication
    Dalile, Boushra
    Van Oudenhove, Lukas
    Vervliet, Bram
    Verbeke, Kristin
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (08) : 461 - 478
1234567